SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 6th, 2023 • Kazia Therapeutics LTD • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”), dated as of November 30, 2023, is between Kazia Therapeutics Limited, a company incorporated under the laws of Australia (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
PLACEMENT AGENT WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES KAZIA THERAPEUTICS LIMITEDSecurities Agreement • December 6th, 2023 • Kazia Therapeutics LTD • Pharmaceutical preparations
THIS PLACEMENT AGENT WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES (the “Warrant”) certifies that, for value received, _________________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after December 5, 2023 (the “Initial Exercise Date”) on or prior to 5:00 p.m. (New York City time) on November 30, 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Kazia Therapeutics Limited, a company incorporated under the laws of Australia (the “Company”), up to _________ ordinary shares, no par value per share (the “Ordinary Shares”), of the Company (the “Warrant Shares”) represented by _________ American Depositary Shares (each, an “ADS” and, collectively, the “ADSs” and the ADSs issuable upon exercise of this Warrant, the “Warrant ADSs”), as subject to adjustment hereunder. The purchase price of one Warrant ADS s
LOCK-UP AGREEMENTLock-Up Agreement • December 6th, 2023 • Kazia Therapeutics LTD • Pharmaceutical preparations
Re: Securities Purchase Agreement, dated as of November 30, 2023, between Kazia Therapeutics Limited (the “Company”) and the purchasers signatory thereto (the “Purchasers”)
